AMICUS THERAPEUTICS, INC. — Director's Dealing 2021

Mar 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-04-15

Reporting Person: Prout Samantha (Principal Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-15	Common Stock	A	8673	—	Acquired	34928	Direct
2020-08-17	Common Stock	A	30181	—	Acquired	65109	Direct
2021-03-26	Common Stock	F	435	$9.59	Disposed	64674	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-15	Stock Options (right to buy)	$10.03	A	13768	Acquired	2030-04-15	Common Stock (13768)	Direct

Footnotes

F1: The Restricted Stock Units will vest in four equal annual installments beginning on April 15, 2021.

F2: The Restricted Stock Units will vest over a three year period, with 50% of the grant vesting on the second anniversary of the grant date and the remaining 50% vesting on the third anniversary of the grant date.

F3: These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant
and the remaining 75% vesting ratably each month thereafter.